Skip to main content
Top

Drugs

Issue 7/2019

Content (11 Articles)

Are All Dopamine Agonists Essentially the Same?

Margherita Torti, Daniele Bravi, Laura Vacca, Fabrizio Stocchi

New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship

Shio-Shin Jean, Ian M. Gould, Wen-Sen Lee, Po-Ren Hsueh

The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice

Antonio Ceriello, Valeria De Nigris, Hiroaki Iijima, Takahiro Matsui, Maki Gouda

Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  • Systematic Review

Federica Fogacci, Nicola Ferri, Peter P. Toth, Massimiliano Ruscica, Alberto Corsini, Arrigo F. G. Cicero

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia

Young-A. Heo, Yahiya Y. Syed, Susan J. Keam

Brexanolone: First Global Approval

Lesley J. Scott

Correction to: Sarecycline: First Global Approval

  • Open Access
  • Correction

Emma D. Deeks

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images